“Plant-Based Hormones”的搜索结果，显示 71-80 项，共有 749 项

1. 外科 - 临床试验- 妙佑医疗国际

   This is an open label, phase I/II, multi-center study in adult participants with metastatic hormone sensitive prostate cancer (mHSPC) and with metastatic ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate the effectiveness of cilta-cel OOS based on overall response of partial response (PR) or better (overall response ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... hormone receptor positive/HER2-negative breast cancer. A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies. Rochester ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Participants in both Phase 1 and 2 will be selected for treatment with \[177Lu\]Lu FAP 2286 based on \[68Ga\]Ga FAP 2286 imaging for determining tumor FAP ...

5. 麻醉与围术期医学科- 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate the hormonal profile related to opioid-induced hypogonadism (OIH) in chronic pain patients before and after ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   (Z)-endoxifen belongs to a group of drugs called selective estrogen receptor modulators or "SERM", which help block estrogen from attaching to cancer cells.

7. 外科 - 临床试验- 妙佑医疗国际

   This is an open label, phase I/II, multi-center study in adult participants with metastatic hormone sensitive prostate cancer (mHSPC) and with metastatic ...

8. 女性化激素治疗- 医生与科室- 妙佑医疗国际

   AskMayoExpert. Gender-affirming hormone therapy (adult). Mayo Clinic; 2022. Medical review (expert opinion). Mayo Clinic. Feb. 7, 2024. 相关. 性别焦虑症. 产品 ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   (Z)-endoxifen belongs to a group of drugs called selective estrogen receptor modulators or "SERM", which help block estrogen from attaching to cancer cells.

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    ... hormonal therapy have more hair loss than patients who are not getting such. Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic ...